A Randomized Controlled Trial of the Efficacy and Safety of CCX282-B, an Orally-Administered Blocker of Chemokine Receptor CCR9, for Patients with Crohn’s Disease-Reference-Cited by-同舟云学术

A Randomized Controlled Trial of the Efficacy and Safety of CCX282-B, an Orally-Administered Blocker of Chemokine Receptor CCR9, for Patients with Crohn’s Disease

Published:2013-03-20 Issue:3 Volume:8 Page:e60094
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Keshav Satish,Vaňásek Tomáš,Niv Yaron,Petryka Robert,Howaldt Stephanie,Bafutto Mauro,Rácz István,Hetzel David,Nielsen Ole Haagen,Vermeire Séverine,Reinisch Walter,Karlén Per,Schreiber Stefan,Schall Thomas J.,Bekker Pirow,

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference20 articles.

1. Clinical patterns in Crohn’s disease: a statistical study of 615 cases;RG Farmer;Gastroenterology,1975

2. The many roles of chemokines and chemokine receptors in inflammation;IF Charo;N Engl J Med,2006

3. Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis;BA Zabel;J Exp Med,1999

4. Cutting edge: identification of the orphan chemokine receptor GPR-9-6 as CCR9, the receptor for the chemokine TECK;A Zaballos;J Immunol,1999

5. Involvement of CCL25 (TECK) in the generation of the murine small-intestineal CD8αα+CD3+ intraepithelial lymphocyte compartment;J Marsal;Eur J Immunol,2002

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T cell trafficking in human chronic inflammatory diseases;iScience;2024-08

2. Challenges and opportunities in inflammatory bowel disease: from current therapeutic strategies to organoid-based models;Inflammation Research;2024-02-12

3. Role of chemokine receptors in transplant rejection and graft-versus-host disease;International Review of Cell and Molecular Biology;2024

4. Role of chemokine receptors in gastrointestinal mucosa;International Review of Cell and Molecular Biology;2024

5. Understanding the molecular mechanisms of anti-trafficking therapies and their clinical relevance in inflammatory bowel disease;Mucosal Immunology;2023-12